Coronavirus: Tracking India's coronavirus vaccine progress

First Published 11, Oct 2020, 11:17 AM

The central government plans to provide Covid vaccines to around 25 crore people out of the country total population of 130 crore by July 2021. 

<p style="text-align: justify;">The central government plans to provide Covid vaccines to around 25 crore people out of the country total population of 130 crore by July 2021. The target is to procure between 400 and 500 million vaccine doses on equitable access basis. But are we any closer to a vaccine? Let's find out</p>

The central government plans to provide Covid vaccines to around 25 crore people out of the country total population of 130 crore by July 2021. The target is to procure between 400 and 500 million vaccine doses on equitable access basis. But are we any closer to a vaccine? Let's find out

<p>Vaccine 1: Covishield<br />
Company: Serum Insititute of India<br />
Number of volunteers: 1600<br />
Status of trial: Phase 3 ongoing<br />
Type of vaccine: Non-replicating viral vector (chimp adenovirus)</p>

Vaccine 1: Covishield
Company: Serum Insititute of India
Number of volunteers: 1600
Status of trial: Phase 3 ongoing
Type of vaccine: Non-replicating viral vector (chimp adenovirus)

<p>Vaccine 2: Sputnik V<br />
Company: Dr Reddy's + Gamaleya Research Institute<br />
Number of volunteers: 76<br />
Status of trial: Permission sought for phase 3<br />
Type of vaccine: Non-replicating viral vector (human adenovirus)</p>

Vaccine 2: Sputnik V
Company: Dr Reddy's + Gamaleya Research Institute
Number of volunteers: 76
Status of trial: Permission sought for phase 3
Type of vaccine: Non-replicating viral vector (human adenovirus)

<p>Vaccine 3: Covaxin<br />
Company: Bharat Biotech<br />
Number of volunteers: 1125<br />
Status of trial: Phase 2 ongoing<br />
Type of vaccine: Whole virion inactivated vaccine</p>

Vaccine 3: Covaxin
Company: Bharat Biotech
Number of volunteers: 1125
Status of trial: Phase 2 ongoing
Type of vaccine: Whole virion inactivated vaccine

<p>Vaccine 4: ZyCov-D<br />
Company: Zydus Cadila<br />
Number of volunteers: 1048<br />
Status of trial: Phase 2 ongoing<br />
Type of vaccine: Plasmid DNA<br />
&nbsp;</p>

Vaccine 4: ZyCov-D
Company: Zydus Cadila
Number of volunteers: 1048
Status of trial: Phase 2 ongoing
Type of vaccine: Plasmid DNA
 

<p>Vaccine 5: RBD Vaccine<br />
Company: Biologicale + Baylor College of Medicine<br />
Number of volunteers: 400<br />
Status of trial: Permission sought for phase 3<br />
Type of vaccine: Recombinant protein vaccine</p>

Vaccine 5: RBD Vaccine
Company: Biologicale + Baylor College of Medicine
Number of volunteers: 400
Status of trial: Permission sought for phase 3
Type of vaccine: Recombinant protein vaccine

loader